Precision BioSciences Reports Second Quarter 2020 Financial Results and Provides Business Update

    NEXT STORY
    Zai Lab Announces Financial Results for Six Months Ended June 30, 2020 and Corporate Updates
    PREV STORY
    ProMIS Neurosciences Announces Second Quarter 2020 Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Achaogen Unveils Data Highlighting the Effectiveness of Plazomicin Against MDR Gram-Negative Bacteria at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

    -- Evaluation of EPIC Phase 3 data demonstrates sustained clinical cure with plazomicin compared ...

    author_avatar
    NASDAQ Market News

    Generic Solid Dosage Forms Report: Competitive Picture for Generic Tablets and Capsules in Two Dozen Drug Classes

    Dublin, Feb. 02, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition ...

    author_avatar
    NASDAQ Market News

    Adverum Biotechnologies Doses First Patient in the ADVANCE Phase 1/2 Clinical Trial of ADVM-043 for A1AT Deficiency

    -- Company Expects to Report Preliminary Data in the Second Half of 2018 -- ...

    author_avatar
    NASDAQ Market News